Aggregate Response Benefit in Skin Clearance and Itch Reduction With Upadacitinib or Dupilumab in Patients With Moderate-to-Severe Atopic Dermatitis®

  • Jonathan I. Silverberg
  • , Marjolein de Bruin-Weller
  • , Brian M. Calimlim
  • , Xiaofei Hu
  • , Sarah A. Ofori
  • , Andrew M. Platt
  • , Henrique D. Teixeira
  • , Kilian Eyerich
  • , Jacob P. Thyssen

Publikation: Beitrag in Fachzeitschrift › Artikel › Begutachtung

1 Zitat (Scopus)

Fingerprint

Untersuchen Sie die Forschungsthemen von „Aggregate Response Benefit in Skin Clearance and Itch Reduction With Upadacitinib or Dupilumab in Patients With Moderate-to-Severe Atopic Dermatitis®“. Zusammen bilden sie einen einzigartigen Fingerprint.

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology